The partnership will leverage Glytec’s insulin dosing support software to address challenges with hospital inpatient blood sugar management, reports Amanda Pedersen, writing for medical device
Abbott’s FreeStyle Libre 3 system is now on the NHS’s new Insulin Pumps, Continuous Glucose Monitoring, Closed Loop Insulin Delivery Systems and Associated Products framework
New research has shown that having higher levels of liver fat, and a smaller pancreas both directly increase the risk of developing Type 2 diabetes.
Type 1 diabetic Elise Quarrington has opened an online diabetes store from which she sells a selection of diabetes accessories). She tells us, “My main
This is our last issue this year, and it ends with a bang, in as much as it’s been great to be able to bring
Insulin gains currency as a limited edition coin from the Royal Mint bears reference to its discovery 100 years ago. We hear from the designer
If you thought that the pandemic might impede progress in the diabetes care arena, nothing could be further from the truth. As this issue shows,
On 14 July Eli Lilly and Company announced the acquisition of Protomer Technologies (“Protomer”), a private biotech company. Protomer’s proprietary peptide- and protein-engineering platform is
Ascensia Diabetes Care has launched a patient assistance programme in the US to provide broader access to its Eversense CGM system. Under the programme eligible
By Ricky Zipp writing for MedTechDive July 2021, “Dexcom wins FDA nod for real-time artificial pancreas systems (APIs), allowing third-party developers access to CGM data
